Consolidated quarter revenue up 38.5%, profit after tax up 91.1%; SNP investment approved
SMT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated revenue for the quarter ended September 30, 2026 was Rs 415.40 crore, up 38.5% from Rs 299.83 crore a year earlier; profit after tax rose 91.1% to Rs 23.01 crore from Rs 12.04 crore. For the half-year ended September 30, 2026, revenue was Rs 781.64 crore and profit after tax was Rs 46.62 crore. The board approved up to USD 0.78 million for promoter-linked SNP Medical, potentially lifting the stake to 17.19%.
Strong revenue and profit growth may support the stock. The small SNP deal is linked to the promoter, so investors should watch deal terms.
The filed figures for this quarter have not reached us in XBRL yet, so there is nothing to compute here; the read above is the AI's, from the document. The table appears the moment the figures land.